In the end all of the temporary manipulation, nudging, framing etcetera is irrelevant. Will Cydy make it or not?
They will, without a doubt in my mind. Cydy started out fighting HIV and evidence of the importance of CCR5 regarding cancer (metastases) and inflamation is growing daily.
If Leronlimab works in accordance with the outcomes of preclinical research it'll be impossible to put a price tag on the Cydy share.
This is a once in a lifetime investment opportunity imo.